FDA Takes Steps to Maintain Newborn Access to Life-Saving Starter Nutrition Products
- FDA: 18 events in the last 90 days
- Previous: earlier the same day · FDA Grants Accelerated Approval to a New Breast Cancer Treatment
What happened
The U.S. Food and Drug Administration today announced it is taking action, consistent with the Trump administration’s commitment to protecting vulnerable patients and maintaining access to critical medical products, to help address a potential supply gap of neonatal starter parenteral nutrition (PN)
Summary assembled by rule from the sources below